Trials / Completed
CompletedNCT00386191
Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment
Evaluation of the Safety and Efficacy of Clopidogrel sulfate50mg and Clopidogrel Sulfate 75mg for the Treatment of Cerebral Infarction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,110 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to compare the safety of clopidogrel 50mg and 75mg in cerebral infarction with respect to incidence of bleeding adverse events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | clopidogrel (SR25990C) | oral administration |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2006-10-11
- Last updated
- 2010-02-24
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00386191. Inclusion in this directory is not an endorsement.